These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 19436687)
1. Identifying potentially cost effective chronic care programs for people with COPD. Steuten LM; Lemmens KM; Nieboer AP; Vrijhoef HJ Int J Chron Obstruct Pulmon Dis; 2009; 4():87-100. PubMed ID: 19436687 [TBL] [Abstract][Full Text] [Related]
2. Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis. Jordan RE; Majothi S; Heneghan NR; Blissett DB; Riley RD; Sitch AJ; Price MJ; Bates EJ; Turner AM; Bayliss S; Moore D; Singh S; Adab P; Fitzmaurice DA; Jowett S; Jolly K Health Technol Assess; 2015 May; 19(36):1-516. PubMed ID: 25980984 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of the COPD Patient Management European Trial home-based disease management program. Bourbeau J; Granados D; Roze S; Durand-Zaleski I; Casan P; Köhler D; Tognella S; Viejo JL; Dal Negro RW; Kessler R Int J Chron Obstruct Pulmon Dis; 2019; 14():645-657. PubMed ID: 30936689 [TBL] [Abstract][Full Text] [Related]
4. An analysis of the economic and patient outcome impact of an integrated COPD service in east London. Garner A; Hodson M; Ketsetzis G; Pulle L; Yorke J; Bhowmik A Int J Chron Obstruct Pulmon Dis; 2017; 12():1653-1662. PubMed ID: 28652718 [TBL] [Abstract][Full Text] [Related]
7. Cost-utility analysis of a pharmacy-led self-management programme for patients with COPD. Khdour MR; Agus AM; Kidney JC; Smyth BM; McElnay JC; Crealey GE Int J Clin Pharm; 2011 Aug; 33(4):665-73. PubMed ID: 21643784 [TBL] [Abstract][Full Text] [Related]
8. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities. Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302 [TBL] [Abstract][Full Text] [Related]
9. Costs of COPD exacerbations in the emergency department and inpatient setting. Dalal AA; Shah M; D'Souza AO; Rane P Respir Med; 2011 Mar; 105(3):454-60. PubMed ID: 20869226 [TBL] [Abstract][Full Text] [Related]
10. Home-based pulmonary rehabilitation for COPD using minimal resources: An economic analysis. Burge AT; Holland AE; McDonald CF; Abramson MJ; Hill CJ; Lee AL; Cox NS; Moore R; Nicolson C; O'Halloran P; Lahham A; Gillies R; Mahal A Respirology; 2020 Feb; 25(2):183-190. PubMed ID: 31418515 [TBL] [Abstract][Full Text] [Related]
11. Dedicated Perioperative Hip Fracture Comanagement Programs are Cost-effective in High-volume Centers: An Economic Analysis. Swart E; Vasudeva E; Makhni EC; Macaulay W; Bozic KJ Clin Orthop Relat Res; 2016 Jan; 474(1):222-33. PubMed ID: 26260393 [TBL] [Abstract][Full Text] [Related]
12. Expanding The INSPIRED COPD Outreach Program™ to the emergency department: a feasibility assessment. Gillis D; Demmons J; Rocker G Int J Chron Obstruct Pulmon Dis; 2017; 12():1597-1604. PubMed ID: 28615932 [TBL] [Abstract][Full Text] [Related]
13. Determinants of healthcare utilization and costs in COPD patients: first longitudinal results from the German COPD cohort COSYCONET. Byng D; Lutter JI; Wacker ME; Jörres RA; Liu X; Karrasch S; Schulz H; Vogelmeier C; Holle R Int J Chron Obstruct Pulmon Dis; 2019; 14():1423-1439. PubMed ID: 31308648 [TBL] [Abstract][Full Text] [Related]
14. Impact of an integrated disease management program in reducing exacerbations in patients with severe asthma and COPD. Jain VV; Allison R; Beck SJ; Jain R; Mills PK; McCurley JW; Van Gundy KP; Peterson MW Respir Med; 2014 Dec; 108(12):1794-800. PubMed ID: 25294691 [TBL] [Abstract][Full Text] [Related]
15. Clinical and economic burden of dyspnea and other COPD symptoms in a managed care setting. Stephenson JJ; Wertz D; Gu T; Patel J; Dalal AA Int J Chron Obstruct Pulmon Dis; 2017; 12():1947-1959. PubMed ID: 28740375 [TBL] [Abstract][Full Text] [Related]
16. Specialized community-based care: an evidence-based analysis. Health Quality Ontario Ont Health Technol Assess Ser; 2012; 12(20):1-60. PubMed ID: 23226812 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of pharmacotherapy for COPD in ambulatory care: a review. Simoens S J Eval Clin Pract; 2013 Dec; 19(6):1004-11. PubMed ID: 23590144 [TBL] [Abstract][Full Text] [Related]
18. Cost Savings from Reduced Hospitalizations with Use of Home Noninvasive Ventilation for COPD. Coughlin S; Peyerl FW; Munson SH; Ravindranath AJ; Lee-Chiong TL Value Health; 2017 Mar; 20(3):379-387. PubMed ID: 28292482 [TBL] [Abstract][Full Text] [Related]
19. An international randomized study of a home-based self-management program for severe COPD: the COMET. Bourbeau J; Casan P; Tognella S; Haidl P; Texereau JB; Kessler R Int J Chron Obstruct Pulmon Dis; 2016; 11():1447-51. PubMed ID: 27418817 [TBL] [Abstract][Full Text] [Related]
20. Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan. Chiang CH Respirology; 2008 Sep; 13(5):689-94. PubMed ID: 18513247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]